HSBC Holdings
TAK icon

HSBC Holdings’s Takeda Pharmaceutical TAK Stock Holding History

HSBC Holdings’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-168,754
Closed -$2.65M – 2844
2023
Q2 		$2.65M Buy
+168,754
New +$2.76M ﹤0.01% 1319
2019
Q2 		– Sell
-31,795
Closed -$648K – 2849
2019
Q1 		$648K Buy
+31,795
New +$640K ﹤0.01% 2005

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HSBC Holdings's TAK Position: Q3 2023 in Review

HSBC Holdings sold out of Takeda Pharmaceutical (TAK) in Q3 2023, closing a stake of 168,754 shares — an estimated $2.65M sold.

HSBC Holdings first reported a position in TAK in Q1 2019 and held it in 2 quarters. The position peaked at $2.65M in Q2 2023. 312 funds tracked by Wall St. Rank hold TAK as of Q3 2023.

  • HSBC Holdings reported no remaining Takeda Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • HSBC Holdings sold 168,754 Takeda Pharmaceutical shares in Q3 2023, an estimated $2.65M.
  • HSBC Holdings first reported a position in Takeda Pharmaceutical in Q1 2019 and held it in 2 quarters.
  • HSBC Holdings's Takeda Pharmaceutical position peaked at $2.65M in Q2 2023.
  • 312 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q3 2023.

Based on HSBC Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.